Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)
2019 · Neurology and Therapy · 11 citations
https://doi.org/10.1007/s40120-019-00159-2
A
Annette F. Okai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
117
Citations
5
h-index
5
i10-index
Annette F. Okai is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Peripheral Neuropathies and Disorders & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 5, co-authored 7 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat